Document Detail

Survival of Patients with Small Cell Lung Carcinoma in Taiwan.
MedLine Citation:
PMID:  22269348     Owner:  NLM     Status:  Publisher    
Background: Small cell lung cancer (SCLC) is the most aggressive form of lung cancer. The prognosis for SCLC patients remains unsatisfactory despite advances in chemotherapy. In this study, we sought to clarify the prognosis and treatment patterns of patients with SCLC. Methods: A cohort comprising all patients diagnosed with SCLC between January 2004 and December 2006 was assembled from the Taiwan Cancer Database. Patients were followed up until December 31, 2009, to determine overall survival. Patient survival was estimated using the Kaplan-Meier method, and Cox's proportional hazard model was used to determine the relationship between prognostic factors and median survival time. Results: Among the 1,684 patients diagnosed with SCLC, 1,215 (72%) were diagnosed with extensive-stage disease and 469 (28%) with limited-stage disease. Most of the patients were male (90%). The median survival duration of patients with limited-stage and extensive-stage SCLC was 10.3 months and 5.6 months, respectively. For limited-stage patients, surgery, chemotherapy, and combined chemotherapy and radiotherapy resulted in better survival than best supportive care (HR 0.20, p < 0.001; HR 0.61, p < 0.001, and HR 0.37, p < 0.001, respectively). For extensive-stage patients, male gender was significantly associated with a poor prognosis (HR 1.45, p < 0.001) and chemotherapy was shown to improve overall survival more effectively than best supportive care (HR 0.37, p < 0.001). Conclusion: For limited-stage SCLC patients, surgery, chemotherapy, and combined chemotherapy and radiotherapy improved survival compared to best supportive care. Extensive-stage SCLC patients benefited more from chemotherapy treatment than from best supportive care.
Yu-Hsuan Kuo; Zhong-Zhe Lin; Yen-Yun Yang; Yu-Yun Shao; Wen-Yi Shau; Raymond N C Kuo; James Chih-Hsin Yang; Mei-Shu Lai
Related Documents :
17670728 - Video-assisted thoracoscopic lobectomy vs. conventional lobectomy via open thoracotomy ...
17415848 - Survival of patients with resected piiia - n2 non small cell lung cancer: suggestion fo...
3600008 - Computed tomography for the evaluation of intrathoracic invasion by lung cancer.
25023758 - Contemporary controversies and perspectives in the staging and treatment of patients wi...
22146128 - Treatment of amelanotic choroidal melanoma with photodynamic therapy.
25164908 - Two biomarker-directed randomized trials in european and chinese patients with non-smal...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-1-20
Journal Detail:
Title:  Oncology     Volume:  82     ISSN:  1423-0232     ISO Abbreviation:  -     Publication Date:  2012 Jan 
Date Detail:
Created Date:  2012-1-24     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0135054     Medline TA:  Oncology     Country:  -    
Other Details:
Languages:  ENG     Pagination:  19-24     Citation Subset:  -    
Copyright Information:
Copyright © 2012 S. Karger AG, Basel.
Department of Oncology, National Taiwan University Hospital Yun-Lin Branch, Yunlin, Taiwan, ROC.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Transcriptional enhancers in development and disease.
Next Document:  Neutrophil depletion reduces edema formation and tissue loss following traumatic brain injury in mic...